Anna L. Blobaum, Ph.D. - Publications
Affiliations: | 2004 | University of Michigan, Ann Arbor, Ann Arbor, MI |
Area:
Pharmacology, BiochemistryYear | Citation | Score | |||
---|---|---|---|---|---|
2006 | Blobaum AL. Mechanism-based inactivation and reversibility: is there a new trend in the inactivation of cytochrome p450 enzymes? Drug Metabolism and Disposition: the Biological Fate of Chemicals. 34: 1-7. PMID 16369051 DOI: 10.1124/dmd.105.004747 | 0.57 | |||
2005 | Blobaum AL, Harris DL, Hollenberg PF. P450 active site architecture and reversibility: inactivation of cytochromes P450 2B4 and 2B4 T302A by tert-butyl acetylenes. Biochemistry. 44: 3831-44. PMID 15751959 DOI: 10.1021/Bi0478953 | 0.614 | |||
2004 | Blobaum AL, Lu Y, Kent UM, Wang S, Hollenberg PF. Formation of a novel reversible cytochrome P450 spectral intermediate: role of threonine 303 in P450 2E1 inactivation. Biochemistry. 43: 11942-52. PMID 15379534 DOI: 10.1021/Bi048882S | 0.634 | |||
2004 | von Weymarn LB, Blobaum AL, Hollenberg PF. The mechanism-based inactivation of p450 2B4 by tert-butyl 1-methyl-2-propynyl ether: structural determination of the adducts to the p450 heme. Archives of Biochemistry and Biophysics. 425: 95-105. PMID 15081898 DOI: 10.1016/J.Abb.2004.03.014 | 0.612 | |||
2004 | Blobaum AL, Kent UM, Alworth WL, Hollenberg PF. Novel reversible inactivation of cytochrome P450 2E1 T303A by tert-butyl acetylene: the role of threonine 303 in proton delivery to the active site of cytochrome P450 2E1. The Journal of Pharmacology and Experimental Therapeutics. 310: 281-90. PMID 14988423 DOI: 10.1124/Jpet.104.065508 | 0.639 | |||
2002 | Blobaum AL, Kent UM, Alworth WL, Hollenberg PF. Mechanism-based inactivation of cytochromes P450 2E1 and 2E1 T303A by tert-butyl acetylenes: characterization of reactive intermediate adducts to the heme and apoprotein. Chemical Research in Toxicology. 15: 1561-71. PMID 12482238 DOI: 10.1021/Tx020052X | 0.638 | |||
Show low-probability matches. |